Benjamin Ruprecht

发表

The target landscape of clinical kinase drugs

Heiner Koch, B. Kuster, R. Preissner, 2017, Science.

Comprehensive and Reproducible Phosphopeptide Enrichment Using Iron Immobilized Metal Ion Affinity Chromatography (Fe-IMAC) Columns

Heiner Koch, B. Kuster, S. Lemeer, 2014, Molecular & Cellular Proteomics.

MALDI‐TOF and nESI Orbitrap MS/MS identify orthogonal parts of the phosphoproteome

B. Kuster, S. Lemeer, Benjamin Ruprecht, 2016, Proteomics.

Preferential microRNA targeting revealed by in vivo competitive binding and differential Argonaute immunoprecipitation

B. Kuster, Benjamin Ruprecht, S. Engelhardt, 2017, Nucleic acids research.

Proteome activity landscapes of tumor cell lines determine drug responses

B. Kuster, Mathias Wilhelm, W. Weichert, 2020, Nature Communications.

DMSO enhances electrospray response, boosting sensitivity of proteomic experiments

Bernhard Kuster, Dominic Helm, Hannes Hahne, 2013, Nature Methods.

Development of phospho- and chemoproteomic methods to study cellular signaling

Benjamin Ruprecht, 2016 .

Proteomic analysis of phosphorylation in cancer

S. Lemeer, Benjamin Ruprecht, 2014, Expert review of proteomics.

Atomic-Resolution Prediction of Degrader-mediated Ternary Complex Structures by Combining Molecular Simulations with Hydrogen Deuterium Exchange

Samuel D. Lotz, João V. Ribeiro, Asghar M. Razavi, 2021, bioRxiv.

Phosphoproteome Profiling Reveals Molecular Mechanisms of Growth-Factor-Mediated Kinase Inhibitor Resistance in EGFR-Overexpressing Cancer Cells.

Heiner Koch, B. Kuster, Mathias Wilhelm, 2016, Journal of proteome research.

Predicting the structural basis of targeted protein degradation by integrating molecular dynamics simulations with structural mass spectrometry

Samuel D. Lotz, João V. Ribeiro, Asghar M. Razavi, 2022, Nature Communications.

Ion Mobility Tandem Mass Spectrometry Enhances Performance of Bottom-up Proteomics

Mathias Wilhelm, Bernhard Kuster, Johannes P C Vissers, 2014, Molecular & Cellular Proteomics.

Comparing immobilized kinase inhibitors and covalent ATP probes for proteomic profiling of kinase expression and drug selectivity.

Bernhard Kuster, Simone Lemeer, B. Kuster, 2013, Journal of proteome research.

Chemoproteomic proﬁling to identify activity changes and functional inhibitors of DNA-binding proteins

Hannes Hahne, Benjamin Ruprecht, I. Cornella-Taracido, 2022 .

Pharmacoproteomic characterisation of human colon and rectal cancer

Heiner Koch, B. Kuster, Mathias Wilhelm, 2017, Molecular systems biology.

A bead-based western for high-throughput cellular signal transduction analyses

B. Kuster, T. Fehm, Benjamin Ruprecht, 2016, Nature Communications.

Characterization of a chemical affinity probe targeting Akt kinases.

B. Kuster, Benjamin Ruprecht, G. Médard, 2013, Journal of proteome research.

A mass spectrometry-based proteome map of drug action in lung cancer cell lines

Andy Liaw, M. Glick, Benjamin Ruprecht, 2020, Nature Chemical Biology.

Proteome activity landscapes of tumor cell lines determine drug responses

B. Kuster, Mathias Wilhelm, W. Weichert, 2020, Nature Communications.

Optimized chemical proteomics assay for kinase inhibitor profiling.

B. Kuster, Mathias Wilhelm, Susan Klaeger, 2015, Journal of proteome research.

Characterization of a high field Orbitrap mass spectrometer for proteome analysis

B. Kuster, S. Lemeer, Benjamin Ruprecht, 2013, Proteomics.

Evaluation of Kinase Activity Profiling Using Chemical Proteomics.

B. Kuster, S. Lemeer, S. Heinzlmeir, 2015, ACS chemical biology.

Lapatinib Resistance in Breast Cancer Cells Is Accompanied by Phosphorylation-Mediated Reprogramming of Glycolysis.

Bernhard Kuster, Wei Wu, Simone Lemeer, 2017, Cancer research.

Chemoproteomic Selectivity Profiling of PIKK and PI3K Kinase Inhibitors.

B. Kuster, Mathias Wilhelm, S. Heinzlmeir, 2019, ACS chemical biology.

Chemical Proteomics and Structural Biology Define EPHA2 Inhibition by Clinical Kinase Drugs.

B. Kuster, K. Saxena, H. Schwalbe, 2016, ACS chemical biology.

Optimized Enrichment of Phosphoproteomes by Fe-IMAC Column Chromatography.

Heiner Koch, B. Kuster, S. Lemeer, 2017, Methods in molecular biology.

Omomyc Reveals New Mechanisms To Inhibit the MYC Oncogene

John K. Zelina, J. O'neil, Benjamin Ruprecht, 2019, Molecular and Cellular Biology.

Decrypting drug actions and protein modifications by dose- and time-resolved proteomics

Thomas A. Hopf, Florian P Bayer, B. Kuster, 2023, Science.

High pH Reversed-Phase Micro-Columns for Simple, Sensitive, and Efficient Fractionation of Proteome and (TMT labeled) Phosphoproteome Digests.

B. Kuster, Benjamin Ruprecht, D. P. Zolg, 2017, Methods in molecular biology.

Hydrophilic Strong Anion Exchange (hSAX) Chromatography Enables Deep Fractionation of Tissue Proteomes.

B. Kuster, Hannes Hahne, Benjamin Ruprecht, 2017, Methods in molecular biology.

Two serines in the distal C-terminus of the human ß1-adrenoceptor determine ß-arrestin2 recruitment

Benjamin Ruprecht, B. Küster, S. Engelhardt, 2017, PloS one.

Chemical Phosphoproteomics Sheds New Light on the Targets and Modes of Action of AKT Inhibitors.

B. Kuster, Benjamin Ruprecht, S. Sieber, 2021, ACS chemical biology.

High pH Reversed-Phase Micro-Columns for Simple, Sensitive, and Efficient Fractionation of Proteome and (TMT labeled) Phosphoproteome Digests.

B. Kuster, Benjamin Ruprecht, D. P. Zolg, 2017, Methods in molecular biology.

The target landscape of clinical kinase drugs

B. Kuster, R. Preissner, Mathias Wilhelm, 2017, Science.